Showing results (1501-1510 of 1,545) with videos related to
Sort By:
Pageof 155
Eclinicalmedicine|October 4, 2022
The placebo response rate and nocebo events in obesity pharmacological trials. A systematic review and meta-analysisYip Han Chin, Cheng Han Ng, Nicholas Ws Chew, et al.The American Journal of Hospice & Palliative Care|August 21, 2020
Impact of Caring for Terminally Ill Children on Physicians: A Systematic Scoping ReviewLisa Xin Ling Ngiam, Yun Ting Ong, Jun Xuan Ng, et al.Cell Reports|July 25, 2025
Cryo-EM and cryo-ET reveal the molecular architecture and host interactions of mycobacteriophage DougeJitendra Maharana, Chun-Hsiung Wang, Li-An Tsai, et al.Alimentary Pharmacology & Therapeutics|January 30, 2023
The prognostic value of including non-alcoholic fatty liver disease in the definition of metabolic syndromeClarissa Elysia Fu, Jie Ning Yong, Cheng Han Ng, et al.Cell Reports. Medicine|March 18, 2026
Suboptimal therapeutic responses associated with semaglutide in type 2 diabetes and obesity: A meta-analysis of randomized controlled trialsDonghyun Ko, Do Han Kim, Faith Xin Ning Tan, et al.Frontiers in Cardiovascular Medicine|November 8, 2021
Post-ST-Segment Elevation Myocardial Infarction Follow-Up Care During the COVID-19 Pandemic and the Possible Benefit of Telemedicine: An Observational StudyAudrey A Y Zhang, Nicholas W S Chew, Cheng Han Ng, et al.Nature Immunology|August 5, 2020
Mapping systemic lupus erythematosus heterogeneity at the single-cell levelDjamel Nehar-Belaid, Seunghee Hong, Radu Marches, et al.Metabolism: Clinical and Experimental|November 29, 2023
Rising global burden of cancer attributable to high BMI from 2010 to 2019Darren Jun Hao Tan, Cheng Han Ng, Mark Muthiah, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 26, 2024
Prevalence of Chronic Liver Disease in Cholangiocarcinoma: A Meta-AnalysisEthan Kai Jun Tham, Ryan Yanzhe Lim, Benjamin Koh, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 25, 2021
TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibitionSarah Chiang, Varshini Vasudevaraja, Jonathan Serrano, et al.Pageof 155